Biologics - Marketed Products

Reditux™ is the Dr. Reddy’s brand of rituximab, a chimeric murine/human anti-CD20 monoclonal antibody (MAb), and is the world's first biosimilar monoclonal antibody. Reditux™ is used in the treatment of Non-Hodgkin’s Lymphoma, which is a group of cancers arising from lymphocytes, a type of white blood cell.

Click here for the Reditux - launch Press Release

GRAFEEL is one of the hemopoietic growth factors that stimulate the proliferation of neutrophils. Grafeel is produced by a strain of Escherichia coli bearing a genetically engineered plasmid that contains a human G-CSF gene. GRAFEEL regulates the production, maturation, and function of cells of the neutrophil lineage. GRAFEEL is used to treat cancer patients suffering from chemotherapy induced neutropenia.

Please click here to get product details